Globus Medical, Inc.
GMED
$58.17
-$0.08-0.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 184.71% | -48.87% | 63.21% | 546.26% | -147.34% |
| Total Depreciation and Amortization | -3.06% | 1.91% | 5.28% | 14.78% | -22.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.46% | 76.63% | -34.08% | 62.03% | -26.70% |
| Change in Net Operating Assets | -64.79% | -21.78% | 129.80% | -173.79% | 5.91% |
| Cash from Operations | -15.71% | 3.28% | 275.34% | 3.57% | -49.95% |
| Capital Expenditure | -110.99% | 59.21% | -50.92% | 2.70% | -24.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 97.95% | 61.37% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 292.49% | -421.25% | 21.42% | 515.61% | -101.56% |
| Cash from Investing | 226.18% | -595.68% | -44.22% | 77.72% | -114.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -83.80% | 194.76% | 65.09% | 317.17% | 228.17% |
| Repurchase of Common Stock | -20,536.40% | -11.19% | 59.67% | 97.65% | 62.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 54.85% | -179.56% | 10.56% | 88.69% | -1,330.08% |
| Cash from Financing | -1,163.73% | 205.02% | 124.86% | 107.53% | 51.23% |
| Foreign Exchange rate Adjustments | 182.73% | -205.06% | 7.92% | 213.92% | -854.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -299.89% | -23.86% | 276.75% | 149.78% | -160.33% |